STOCK TITAN

IGC Pharma (IGC) PFO Claudia Grimaldi exercises RSUs and options for more shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

IGC Pharma director and PFO Claudia Grimaldi exercised equity awards to acquire additional common stock. On April 1, 2026, she converted 100,000 Restricted Stock Units into 100,000 shares of common stock and exercised options for 138,462 shares at an exercise price of $0.26 per share.

These exercises increased her direct holdings to 1,372,714 shares of common stock. The RSUs and options were originally granted in June 2023 and March 2024, respectively, and vest in equal installments over three years.

Positive

  • None.

Negative

  • None.
Insider GRIMALDI CLAUDIA
Role PFO
Type Security Shares Price Value
Exercise Restricted Stock Units 100,000 $0.00 --
Exercise Options 138,462 $0.00 --
Exercise Common Stock 100,000 $0.00 --
Exercise Common Stock 138,462 $0.26 $36K
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Options — 221,538 shares (Direct); Common Stock — 1,234,252 shares (Direct)
Footnotes (1)
  1. On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2024. On March 13, 2024, the Reporting Person was granted Options subject to vesting equally over three years starting in March 2025. The exercise price is $0.26. Each restricted stock unit represents a right to receive one share of IGC common stock.
RSUs exercised 100,000 shares Converted from Restricted Stock Units into common stock on April 1, 2026
Options exercised 138,462 shares Options exercised into common stock on April 1, 2026
Total shares acquired 238,462 shares Combined RSU and option exercises on April 1, 2026
Exercise price $0.26 per share Stock options granted March 13, 2024
Post-transaction holdings 1,372,714 shares Common stock directly owned after exercises
RSU grant date June 20, 2023 RSUs vest equally over three years starting March 2024
Option grant date March 13, 2024 Options vest equally over three years starting March 2025
Restricted Stock Units financial
"On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
exercise price financial
"The exercise price is $0.26."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"subject to vesting equally over three years starting on March 2024"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Common Stock financial
"Each restricted stock unit represents a right to receive one share of IGC common stock."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GRIMALDI CLAUDIA

(Last)(First)(Middle)
10224 FALLS ROAD

(Street)
POTOMAC MARYLAND 20854

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
IGC Pharma, Inc. [ IGC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
PFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/01/2026M100,000(1)A$0.01,234,252D
Common Stock04/01/2026M138,462(1)A$0.261,372,714D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(3)04/01/2026M100,000(1) (1) (1)Common Stock100,000$0.00D
Options$0.2604/01/2026M138,462(2) (2)03/12/2034Common Stock138,462$0.0221,538D
Explanation of Responses:
1. On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2024.
2. On March 13, 2024, the Reporting Person was granted Options subject to vesting equally over three years starting in March 2025. The exercise price is $0.26.
3. Each restricted stock unit represents a right to receive one share of IGC common stock.
/s/ Claudia Grimaldi04/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did IGC (IGC) report for Claudia Grimaldi?

IGC reported that director and PFO Claudia Grimaldi exercised equity awards to acquire common stock. She converted 100,000 Restricted Stock Units and exercised options for 138,462 shares, increasing her direct stake in IGC Pharma’s common stock.

How many IGC (IGC) shares did Claudia Grimaldi acquire in this Form 4?

Claudia Grimaldi acquired 238,462 shares of IGC common stock through derivative exercises. This includes 100,000 shares from Restricted Stock Units and 138,462 shares from stock options, reflecting compensation-related equity rather than open-market purchases.

What is the exercise price of the IGC (IGC) options exercised by Claudia Grimaldi?

The options exercised by Claudia Grimaldi have an exercise price of $0.26 per share. These options were granted on March 13, 2024, and are scheduled to vest in three equal annual installments beginning in March 2025, according to the grant terms.

How many IGC (IGC) shares does Claudia Grimaldi hold after these transactions?

Following the reported transactions, Claudia Grimaldi directly holds 1,372,714 shares of IGC Pharma common stock. This figure reflects her position after converting 100,000 Restricted Stock Units and exercising options for 138,462 additional shares on April 1, 2026.

What are the vesting terms of the IGC (IGC) RSUs and options granted to Claudia Grimaldi?

The RSUs granted on June 20, 2023 vest in three equal annual installments starting March 2024. The options granted on March 13, 2024 vest equally over three years starting in March 2025, providing staged equity compensation over multiple years.

Does this IGC (IGC) Form 4 show any insider share sales?

The Form 4 reports only derivative exercises coded “M,” with no open-market sale transactions. All reported entries reflect the conversion of Restricted Stock Units and options into common shares, indicating equity award vesting rather than selling activity.